blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2391381

EP2391381 - USE OF A SYNERGISTIC COMBINATION OF HYPOTHIOCYANITE AND/OR HYPOHALITE IONS AND LACTOFERRIN FOR PREPARING A TREATMENT FOR CYSTIC FIBROSIS [Right-click to bookmark this link]
Former [2011/49]Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis
[2015/40]
StatusNo opposition filed within time limit
Status updated on  12.08.2016
Database last updated on 15.07.2024
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG
published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
Alaxia
60 Avenue Rockefeller
Bâtiment Adenine
69008 Lyon / FR
[2015/41]
Former [2012/40]For all designated states
Alaxia
60 Avenue Rockefeller
Bâtiment Adenine
69008 Lyon / FR
Former [2011/49]For all designated states
Alaxia
9 et 11 rue de la Perlerie
69120 Vaulx en Velin / FR
Inventor(s)01 / BORDEAU, Philippe
46 Allée Chantalouette
F-69330 Meyzieu / FR
02 / PERRAUDIN, Jean-Paul
9 avenue de la Ferme Rose
B-1180 Bruxelles / BE
 [2011/49]
Representative(s)KATZAROV S.A.
Geneva Business Center
12 Avenue des Morgines
1213 Petit-Lancy / CH
[N/P]
Former [2013/09]KATZAROV S.A.
European Patent Attorneys 19, rue des Epinettes
1227 Genève / CH
Former [2011/49]Tripoz, Inès
CABINET Inès Tripoz 52, rue du Colombier
69007 Lyon / FR
Application number, filing date10707062.528.01.2010
[2015/41]
WO2010FR00070
Priority number, dateFR2009005053628.01.2009         Original published format: FR 0950536
[2011/49]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO2010086530
Date:05.08.2010
Language:FR
[2010/31]
Type: A1 Application with search report 
No.:EP2391381
Date:07.12.2011
Language:FR
The application published by WIPO in one of the EPO official languages on 05.08.2010 takes the place of the publication of the European patent application.
[2011/49]
Type: B1 Patent specification 
No.:EP2391381
Date:07.10.2015
Language:FR
[2015/41]
Search report(s)International search report - published on:EP05.08.2010
ClassificationIPC:A61K38/40, A61K33/18, A61P11/00
[2011/49]
CPC:
A61K33/18 (EP,US); A61K38/40 (EP,US); A61P11/00 (EP);
A61P31/04 (EP)
C-Set:
A61K33/18, A61K2300/00 (EP,US);
A61K38/40, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2015/41]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:VERWENDUNG EINER SYNERGISTISCHEN KOMBINATION VON HYPOTHIOCYANIT UND/ODER HYPOHALIT-IONEN UND LACTOFERRIN ZUR HERSTELLUNG EINER BEHANDLUNG GEGEN ZYSTISCHE FIBROSE[2011/49]
English:USE OF A SYNERGISTIC COMBINATION OF HYPOTHIOCYANITE AND/OR HYPOHALITE IONS AND LACTOFERRIN FOR PREPARING A TREATMENT FOR CYSTIC FIBROSIS[2015/40]
French:UTILISATION D'UNE ASSOCIATION SYNERGIQUE D'IONS HYPOTHIOCYANITES ET/OU HYPOHALITES ET DE LACTOFERRINE POUR LA PRÉPARATION POUR LE TRAITEMENT DE LA MUCOVISCIDOSE[2015/40]
Former [2011/49]Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis
Former [2011/49]Utilisation d'une association synergique d'ions hypothiocyanites et/ou hypohalites et de lactoferrine pour la préparation pour le traitement de la mucoviscidose
Entry into regional phase17.08.2011National basic fee paid 
17.08.2011Designation fee(s) paid 
17.08.2011Examination fee paid 
Examination procedure17.08.2011Amendment by applicant (claims and/or description)
17.08.2011Examination requested  [2011/49]
04.12.2013Despatch of a communication from the examining division (Time limit: M04)
27.03.2014Reply to a communication from the examining division
27.05.2015Communication of intention to grant the patent
21.08.2015Fee for grant paid
21.08.2015Fee for publishing/printing paid
21.08.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.12.2013
Opposition(s)08.07.2016No opposition filed within time limit [2016/37]
Fees paidRenewal fee
28.01.2012Renewal fee patent year 03
16.01.2013Renewal fee patent year 04
05.11.2013Renewal fee patent year 05
11.11.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.01.2010
AT07.10.2015
BG07.10.2015
CY07.10.2015
DK07.10.2015
EE07.10.2015
FI07.10.2015
HR07.10.2015
LT07.10.2015
LV07.10.2015
MC07.10.2015
MK07.10.2015
MT07.10.2015
RO07.10.2015
SE07.10.2015
SI07.10.2015
SK07.10.2015
SM07.10.2015
TR07.10.2015
NO07.01.2016
GR08.01.2016
LU28.01.2016
IS07.02.2016
PT08.02.2016
[2018/38]
Former [2018/30]HU28.01.2010
AT07.10.2015
CY07.10.2015
DK07.10.2015
EE07.10.2015
FI07.10.2015
HR07.10.2015
LT07.10.2015
LV07.10.2015
MC07.10.2015
MK07.10.2015
MT07.10.2015
RO07.10.2015
SE07.10.2015
SI07.10.2015
SK07.10.2015
SM07.10.2015
TR07.10.2015
NO07.01.2016
GR08.01.2016
LU28.01.2016
IS07.02.2016
PT08.02.2016
Former [2018/28]HU28.01.2010
AT07.10.2015
CY07.10.2015
DK07.10.2015
EE07.10.2015
FI07.10.2015
HR07.10.2015
LT07.10.2015
LV07.10.2015
MC07.10.2015
MK07.10.2015
MT07.10.2015
RO07.10.2015
SE07.10.2015
SI07.10.2015
SK07.10.2015
SM07.10.2015
NO07.01.2016
GR08.01.2016
LU28.01.2016
IS07.02.2016
PT08.02.2016
Former [2017/47]AT07.10.2015
DK07.10.2015
EE07.10.2015
FI07.10.2015
HR07.10.2015
LT07.10.2015
LV07.10.2015
MC07.10.2015
MT07.10.2015
RO07.10.2015
SE07.10.2015
SI07.10.2015
SK07.10.2015
SM07.10.2015
NO07.01.2016
GR08.01.2016
LU28.01.2016
IS07.02.2016
PT08.02.2016
Former [2016/49]AT07.10.2015
DK07.10.2015
EE07.10.2015
FI07.10.2015
HR07.10.2015
LT07.10.2015
LV07.10.2015
MC07.10.2015
RO07.10.2015
SE07.10.2015
SI07.10.2015
SK07.10.2015
SM07.10.2015
NO07.01.2016
GR08.01.2016
LU28.01.2016
IS07.02.2016
PT08.02.2016
Former [2016/42]AT07.10.2015
DK07.10.2015
EE07.10.2015
FI07.10.2015
HR07.10.2015
LT07.10.2015
LV07.10.2015
MC07.10.2015
RO07.10.2015
SE07.10.2015
SK07.10.2015
SM07.10.2015
NO07.01.2016
GR08.01.2016
LU28.01.2016
IS07.02.2016
PT08.02.2016
Former [2016/39]AT07.10.2015
DK07.10.2015
EE07.10.2015
FI07.10.2015
HR07.10.2015
LT07.10.2015
LV07.10.2015
RO07.10.2015
SE07.10.2015
SK07.10.2015
SM07.10.2015
NO07.01.2016
GR08.01.2016
LU28.01.2016
IS07.02.2016
PT08.02.2016
Former [2016/38]AT07.10.2015
EE07.10.2015
FI07.10.2015
HR07.10.2015
LT07.10.2015
LV07.10.2015
RO07.10.2015
SE07.10.2015
SK07.10.2015
SM07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
Former [2016/36]AT07.10.2015
EE07.10.2015
FI07.10.2015
HR07.10.2015
LT07.10.2015
LV07.10.2015
RO07.10.2015
SE07.10.2015
SK07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
Former [2016/25]AT07.10.2015
FI07.10.2015
HR07.10.2015
LT07.10.2015
LV07.10.2015
SE07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
Former [2016/24]AT07.10.2015
FI07.10.2015
HR07.10.2015
LT07.10.2015
SE07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
Former [2016/23]HR07.10.2015
LT07.10.2015
SE07.10.2015
NO07.01.2016
IS07.02.2016
Former [2016/22]LT07.10.2015
NO07.01.2016
IS07.02.2016
Former [2016/21]LT07.10.2015
NO07.01.2016
Former [2016/20]LT07.10.2015
Cited inInternational search[Y]WO2005113026  (MEDICAL DISCOVERIES INC [US], et al) [Y] 1-14 * paragraph [0015]; example 2; claims 39,41 *;
 [Y]WO2007134180  (LACLEDE INC [US], et al) [Y] 1-14 * paragraph [0085]; examples 1,2,4 *;
 [AD]WO2008003688  (PERRAUDIN JEAN-PAUL [BE]) [AD] 1-14* the whole document *;
 [XP]  - SANDRE-BALLESTER ET AL, "A gift of Nature for the treatment of Pseudomonas aeruginosa", JOURNAL OF CYSTIC FIBROSIS, ELSEVIER LNKD- DOI:10.1016/S1569-1993(09)60116-8, vol. 8, ISSN 1569-1993, (20090601), page S29, (20090601), XP026192287 [XP] 1-14 * abstract *

DOI:   http://dx.doi.org/10.1016/S1569-1993(09)60116-8
 [Y]  - TRAVIS SUE M ET AL, "Activity of abundant antimicrobials of the human airway", AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, (199905), vol. 20, no. 5, ISSN 1044-1549, pages 872 - 879, XP002534861 [Y] 1-14 * page 874; figure 1 *
by applicantUS2002172645
 WO2007134180
 WO2008003688
    - AM. J. RESPIR. CRIT. CARE MED., (2007), vol. 175, no. 9, page 967
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.